Suma M. Krishnan
Founder at KRYSTAL BIOTECH, INC.
Net worth: 276 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Krish S. Krishnan | M | 59 |
Pinnacle Pharmaceuticals LLC
 Pinnacle Pharmaceuticals LLC BiotechnologyHealth Technology Pinnacle Pharmaceuticals LLC developed a novel compound effective against multi-drug-resistant bacterial strains. The company was headquartered in Radford, VA.
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA.
Jeune Aesthetics, Inc.
 Jeune Aesthetics, Inc. BiotechnologyHealth Technology Jeune Aesthetics, Inc. is a biotechnology company. The private company is based in Pittsburgh, PA. | 16 years |
| Daniel Janney | M | 58 | 8 years | |
| Kirti Wardhaman Ganorkar | F | 57 | 7 years | |
| John Thomas | M | - | 3 years | |
| Christopher Mason | M | 66 | 3 years | |
| Bo Lin | F | - | 6 years | |
| E. Sutherland | M | 54 | 2 years | |
| Catherine Mazzacco | F | 59 | 1 years | |
| Julian Gangolli | M | 66 | 5 years | |
| James Turley | M | 68 | 10 years | |
| Meg Dodge | F | - | - | |
| Dino Rossi | M | 69 | 7 years | |
| Jeffrey Perez | M | 52 | 10 years | |
| Garen Z. Manvelian | M | - |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 18 years |
| John Thottathil | M | - |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 18 years |
| Kathryn Romano | F | 43 | 4 years | |
| Josh Suskin | M | - | - | |
| Rachael Borromeo | F | - | - | |
| Marc Forth | M | 54 |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Jeune Aesthetics, Inc. is a biotechnology company. The private company is based in Pittsburgh, PA. | - |
| Stéphane Paquette | M | - | - | |
| John Karakkal | M | - | - | |
| Trevor Parry | M | - | - | |
| Nate Rattner | M | - | - | |
| Ram Kamineni | M | - | 2 years | |
| Samir D. Roy | M | - |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 18 years |
| Hubert Chen | M | - | - | |
| George Chen | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Larry D. Horner | M | 90 |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 16 years |
| Whitney Ijem | F | - | 2 years | |
| Jing Marantz | M | 59 | 1 years | |
| Samuel Broder | M | 79 | 2 years | |
| Rockford Norby | M | 88 | 3 years | |
| John Naftzger | M | 57 | 1 years | |
| Fayaz Khazi | M | 51 | 2 years | |
| Kelly Huang | M | 55 | - | |
| Christopher Basta | M | - | - | |
| Dana di Ferdinando | F | - | - | |
| Olivier R. Jarry | M | 63 | - | |
| Jack Anthony Bobo | M | 58 | - | |
| Chris Savile | M | - | 4 years | |
| Pooja Agarwal | M | 45 | 4 years | |
| Katherine Tuminello | F | - | - | |
| Anne Rogel | F | - | - | |
| Brittani Agostini | F | - | - | |
| Court Freedman | M | - | 3 years | |
| Andrew Orth | M | 54 | 2 years | |
| Stacie Oliver | M | - | 1 years | |
| David Glynn | M | - | - | |
| Tiffany Hamilton | F | - | 1 years | |
| Grace E. Colón | M | 57 | 2 years | |
| Christal Mickle | F | 45 |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 3 years |
| Gregory Ian Frost | M | 52 | 1 years | |
| Marcus E. Smith | M | 69 |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 8 years |
| Anthony Riley | M | 57 | 3 years | |
| Saiid Zarrabian | M | 71 | 1 years | |
| Burton E. Sobel | M | 86 |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 8 years |
| Cesar Alvarez | M | 76 |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 3 years |
| Joel A. Liffmann | M | 63 | 4 years | |
| Peter Seufer-Wasserthal | M | - | 5 years | |
| Roger Griggs | M | - |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | - |
| Bhushan D. Hardas | M | - | 1 years | |
| Travis Mickle | M | 50 |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | 4 years |
| Peter Emtage | M | - | - | |
| Jennifer Chien | F | 49 | - | |
| Matthew Crisp | M | 41 | 1 years | |
| Jim Shaffer | M | 57 |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | - |
| Robert F. Walsh | M | 65 | 6 years | |
| Nir Nimrodi | M | 55 | 5 years | |
| Jayson M. Rieger | M | 48 | 1 years | |
| Tami Martin | F | 68 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 5 years |
| John Garcia | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 71 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Suma M. Krishnan
- Personal Network
